Andere talen Zhejiang Hisun Pharmaceutical Co., Ltd.

Aandelen

600267

CNE0000013Z2

Slotkoers Shanghai S.E. Andere beurzen 11-09-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
7,120 ^CNY	-0,70%		-2,06%	-23,93%

19/08	Zhejiang Hisun Pharmaceutical Co, Ltd. Rapporteert winstresultaten voor het halfjaar dat eindigde op 30 juni 2024	CI
06/08	Hisun Pharmaceutical krijgt goedkeuring om Eltrombopag op de markt te brengen; aandelen stijgen 3%.	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	19/08
Hisun Pharmaceutical Gets Nod to Market Eltrombopag; Shares Up 3%	06/08
Hisun Pharmaceutical's Unit Gets Nod for Veterinary Drug	23/07
Shanghai Anrui Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 48 million in funding from Zhejiang Hisun Pharmaceutical Co., Ltd.	16/07
Hisun Pharmaceutical's Veterinary Arm Gets Registration Certificate for Mirtazapine Ointment	12/07
Hisun Pharmaceutical's Leukemia Drug Passes Chinese Drug Regulator's Consistency Evaluation	27/06
Hisun Pharmaceutical's Leukemia Drug Gets Marketing Approval	27/06
Hisun Pharmaceutical Unit's Cladribine Injection Passes Regulatory Evaluation	19/06
Hisun Pharmaceutical's Veterinary Arm Gets Nod to Produce Fenbendazole Oral Suspension	04/06
Hisun Pharma's Veterinary Arm Gets Approval to Register Amoxicillin and Clavulanate Potassium Dry Suspension	20/05
Hisun Pharma's Veterinary Arm Gets Nod to Market Selamectin Drops	16/05
Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 23, 2023.	20/04
Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback announced on December 23, 2023, has closed with 11,687,200 shares, representing 0.98% for CNY 98.99 million.	18/04
Hisun Pharma's Unit Gets Nod for Pig Vaccine	17/04
Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 23, 2023.	02/04
China Energy Engineering Issues Apology Over Former Director's Stake Disposal Breaches	27/03
Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 23, 2023.	03/01
Zhejiang Hisun Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	23/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zhejiang Hisun Pharmaceutical Co., Ltd.

Aandelen

600267

CNE0000013Z2

Andere talen

Filters